Increased copeptin concentrations are related to a higher mortality in critically ill patients and provide prognostic implications in patients with end stage renal disease [14], heart failure [15], myocardial infarction [16] and stroke [17,18]. The gene discussed is AVP; the disease is chronic kidney disease.